Peppermint OIL
18 of 24 results reported a benefit
9 studies, including a review of trials
Reviews pooling mostly small, older trials of enteric-coated capsules favour peppermint oil, but the two newest trials (189 people in 2020, and a 2021 US trial) missed their main measures, and a 2022 review rated the evidence very low quality.
- Abdominal pain95%higher chance than the comparison groupAverage of 2 results (from 78% higher chance than the comparison group to 2.14 times the chance of the comparison group) · 2 reviews of trials7 of 9 results reported a benefit2019 study 1 ↗2014 study 2 ↗
- Overall IBS symptoms2.31 timesthe chance of the comparison groupAverage of 2 results (from 2.23 times the chance of the comparison group to 2.39 times the chance of the comparison group) · 2 reviews of trials4 of 7 results reported a benefit2019 study 1 ↗2014 study 2 ↗
- IBS symptom severityNo clear differencenegligible standardised effect1 randomised trial1 of 2 results reported a benefit2021 study ↗
No figure given: Abdominal discomfort (reported a benefit).
Also measured alongside: Bloating (abdominal distension) (reported a benefit); Gut noises (borborygmi) (reported a benefit); Stool frequency (reported a benefit); and 2 more.
Every result